LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma-Reference-Cited by-同舟云学术

LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma

Published:2022-08-10 Issue:9 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Gong Yun¹,Lv Yue²^ORCID,Xu Fanghua³,Xiu Youcheng²,Lu Yinhui¹,Liu Zan²,Deng Leihong⁴^ORCID

Affiliation:

1. Health Management Center Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College) Nanchang China

2. Department of Urology The First Affiliated Hospital, Harbin Medical University Harbin China

3. Department of Pathology Pingxiang People's Hospital (Pingxiang Hospital Affiliated to Southern Medical University) Pingxiang China

4. Department of Ultrasound Medicine The First Affiliated Hospital of Nanchang University Nanchang China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24648

Reference24 articles.

1. Renal Cell Carcinoma: Diagnosis and Management;Gray RE;Am Fam Physician,2019

2. Metabolic reprogramming in clear cell renal cell carcinoma

3. Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma

4. Renal Cell Carcinoma: Molecular Aspects

5. Adjuvant therapy in renal cell carcinoma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis;Journal of Cancer Research and Clinical Oncology;2024-01

2. Two-Dimensional-PAGE Coupled with nLC-MS/MS-Based Identification of Differentially Expressed Proteins and Tumorigenic Pathways in MCF7 Breast Cancer Cells Transfected for JTB Protein Silencing;Molecules;2023-11-09